In vitro analyses also showed that tranilast suppressed expression of mesenchymal markers and angiogenesis-related genes, suggesting its potential to inhibit NF1-associated tumor growth through EMT and angiogenesis suppression [121]. This evidence concerns the gene NF1 and neoplasm.